Pharmigene, Inc. (TPEX:7595)

Taiwan · Delayed Price · Currency is TWD

10.20

-0.40 (-3.92%)

Apr 20, 2026, 1:12 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Diagnostic Kits / Equipment	116.53M	132.71M	133.80M	129.35M	102.20M
Diagnostic Kits / Equipment Growth	-12.19%	-0.82%	3.44%	26.57%	54.34%
Adjustment and Write-Off	-	-	-	-	-847.00K
Total	116.53M	132.71M	133.80M	129.35M	101.35M
Total Growth	-12.19%	-0.82%	3.44%	27.63%	55.26%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Taiwan	103.56M	116.39M	119.47M	116.18M	88.46M
Taiwan Growth	-11.02%	-2.57%	2.83%	31.33%	52.34%
Asia	8.95M	13.02M	9.51M	10.60M	11.41M
Asia Growth	-31.31%	36.90%	-10.22%	-7.16%	117.85%
Europe	586.00K	541.00K	3.75M	924.00K	48.00K
Europe Growth	8.32%	-85.58%	306.06%	1825.00%	-87.23%
America	3.44M	2.75M	1.07M	1.66M	2.28M
America Growth	24.97%	157.58%	-35.59%	-27.15%	-10.08%
Income from Internal Divisions	-	-	-	-	-847.00K
Total	116.53M	132.71M	133.80M	129.35M	101.35M
Total Growth	-12.19%	-0.82%	3.44%	27.63%	55.26%

Source: S&P Global Market Intelligence.